Business

mass. movers

Infinity Pharmaceuticals stock slides

One Infinity cancer drug under development targets patients who smoked heavily.

Associated Press

One Infinity cancer drug under development targets patients who smoked heavily.

Advertisement

Leukemia-drug competitors of Infinity Pharmaceuticals Inc., The Wall Street Journal reported, had strong if incremental releases of scientific data about their products Wednesday. But JPMorgan says investors are “increasingly skittish” ahead of June’s American Society of Clinical Oncology conference, at which Infinity is expected to release safety and tolerability data for its drug. The bank predicts “a good showing” by Infinity but warns it may not be enough to outshine the rivals.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.